{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T13:13:41Z","timestamp":1793798021325,"version":"4.6.1"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Equity Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The 2025 clade IIb mpox outbreak in Sierra Leone, intersecting with a significant HIV burden, is not merely a health crisis but a stark manifestation of deep-seated global health inequities. This commentary argues that the response to this outbreak reveals a familiar and fatal pattern: the neglect of diseases within marginalized populations until they threaten high-income countries. Through analyzing disparities in clinical outcomes, diagnostic and therapeutic access, and containment policies, we critique the reactive, charity-based model of global health. We propose a paradigm shift towards proactive equity, centered on the establishment of a permanent infectious disease Equity Fund to ensure the rapid, equitable distribution of vaccines, therapeutics, and diagnostics for future outbreaks, transforming a moment of crisis into an opportunity for durable change.<\/jats:p>","DOI":"10.1186\/s12939-025-02725-7","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T14:55:31Z","timestamp":1767711331000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["From outbreak to opportunity: Sierra Leone\u2019s mpox crisis as a wakeup call for pandemic equity"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-6137-4870","authenticated-orcid":false,"given":"Alpha Umaru","family":"Bai-Sesay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosetta Doreen","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Karim Dauda","family":"Sesay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,6]]},"reference":[{"key":"2725_CR1","doi-asserted-by":"crossref","unstructured":"Hoffmann Dahl E, Jiba DF, Casas EC, Jonckheere S, Dama A, Kyi HA, et al. Monkeypox virus\u2013HIV co-infections in Sierra Leone. Lancet Infect Dis. 2025. S1473-3099(25)00542-0.","DOI":"10.1016\/S1473-3099(25)00542-0"},{"key":"2725_CR2","doi-asserted-by":"crossref","unstructured":"Kangbai JB, Saidu E, Foday IK, Kamanda ES, Jaba M, Campbell A, et al. Clinical and epidemiological characteristics among probable and confirmed patients with mpox in Sierra Leone reported from January to May 2025 [Internet]. medRxiv; 2025 [cited 2025 Sep 20]. p. 2025.05.30.25328691. Available from: https:\/\/www.medrxiv.org\/content\/10.1101\/2025.05.30.25328691v2.","DOI":"10.1101\/2025.05.30.25328691"},{"key":"2725_CR3","unstructured":"CDC US. Clinical Considerations for mpox in immunocompromised people | mpox | CDC [Internet]. 2025 [cited 2025 Sep 20]. Available from: https:\/\/www.cdc.gov\/mpox\/hcp\/clinical-care\/immunocompromised-people.html."},{"key":"2725_CR4","unstructured":"CDC. Mpox. 2025 [cited 2025 Sep 20]. Tecovirimat (TPOXX) for Treatment of mpox. Available from: https:\/\/www.cdc.gov\/mpox\/hcp\/clinical-care\/tecovirimat.html."},{"issue":"15","key":"2725_CR5","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1056\/NEJMoa2412439","volume":"392","author":"The PALM007 Writing Group","year":"2025","unstructured":"The PALM007 Writing Group. Tecovirimat for clade I MPXV infection in the Democratic Republic of Congo. N Engl J Med. 2025;392(15):1484\u201396.","journal-title":"N Engl J Med"},{"key":"2725_CR6","unstructured":"Simon C. Detailed results from PALM007 study: no clinical impact of tecovirimat against mpox clade 1 | HIV i-Base [Internet]. 2024 [cited 2025 Sep 20]. Available from: https:\/\/i-base.info\/htb\/50006."},{"key":"2725_CR7","unstructured":"WHO. Clinical management and infection prevention and control for mpox: living guideline, May 2025 [Internet]. 2025 [cited 2025 Sep 20]. Available from: https:\/\/www.who.int\/publications\/i\/item\/B09434."},{"issue":"2","key":"2725_CR8","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.1093\/cid\/ciaf059","volume":"81","author":"R Bender Ignacio","year":"2025","unstructured":"Bender Ignacio R, Kitahata M, Monta\u00f1o M, Shapiro A. Mpox in people with HIV: prioritizing interventions for those without HIV viral suppression. Clin Infect Dis. 2025;81(2):e37\u20138.","journal-title":"Clin Infect Dis"}],"container-title":["International Journal for Equity in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12939-025-02725-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12939-025-02725-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12939-025-02725-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T14:55:33Z","timestamp":1767711333000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12939-025-02725-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,6]]},"references-count":8,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2725"],"URL":"https:\/\/doi.org\/10.1186\/s12939-025-02725-7","relation":{},"ISSN":["1475-9276"],"issn-type":[{"value":"1475-9276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,6]]},"assertion":[{"value":"22 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2"}}